What should be considered when treating both DLBCL and follicular lymphoma at the same time?
When follicular lymphoma transforms into DLBCL, which happens in about 25 percent to 60 percent of cases, the situation becomes more complex. This transformation makes the disease harder to treat and typically requires more Show Full Answer
What should be considered when treating both DLBCL and follicular lymphoma at the same time?
When follicular lymphoma transforms into DLBCL, which happens in about 25 percent to 60 percent of cases, the situation becomes more complex. This transformation makes the disease harder to treat and typically requires more aggressive therapies.
The key treatment considerations include:
* Confirming the diagnosis is accurate, as DLBCL can mimic other conditions
* Determining if standard R-CHOP chemotherapy is appropriate or if a different approach is needed
* Considering whether this is a scenario where more aggressive treatment is necessary
* Getting a second opinion to ensure the treatment plan is on the right track
Treatment often involves combination chemotherapy regimens like R-CHOP (Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) or other combinations depending on your specific situation.
For prognosis, transformation to DLBCL generally lowers survival rates compared to follicular lymphoma alone. However, DLBCL itself has about a 65 percent five-year survival rate overall. Your individual prognosis will depend on factors like your age, overall health, how well the lymphoma responds to treatment, and specific characteristics of your cancer cells.
The good news is that even with transformation, the condition can still be managed with appropriate care and treatment adjustments.
February 19
Join
Your Privacy Choices
